Sonoma Pharmaceuticals, Inc. (SNOA)
SNOANASDAQ-CMMedical/Dental Instruments
$1.17
+0.1000 (+9.35%) today
Closed, Nov 9, 4:00 PM ET
- Market cap
- $5.41m
- P/E
- –
- EPS, last 4 quarters
- –
- Dividend yield
- –
- Day range
- –
- 52-week range
- $0.8501 to $3.95
- Average volume
- 45.4k
- Previous close
- $1.07
Earnings
Next report Nov 10, 2026
Financials
| Quarter | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| Revenue | $5.60m | $4.35m | $5.56m | $6.41m |
| Gross profit | $2.12m | $1.65m | $2.18m | $2.58m |
| Operating income | -$337.0k | -$678.0k | -$351.0k | -$40.0k |
| Net income | -$534.0k | -$819.0k | -$581.0k | -$330.0k |
Last four quarters: revenue $21.92m, margin -10.3%, free cash flow -$2.65m
News
6 latest- Jade Biosciences Appoints Mark Eisner To The Board Of Directors RTTNews · Jun 26, 2026
- Sonoma Pharma Prices $4 Mln Offering Of Shares And Warrants RTTNews · Apr 27, 2026
- Stocks Moving Premarket: PMNT, KULR, ENLV, ORGN, And Other Gainers & Losers RTTNews · Aug 15, 2025
- SONOMA PHARMACEUTICALS Earnings Preview: Recent $SNOA Insider Trading, Hedge Fund Activity, and MoreQuiver Quantitative · Jun 14, 2025
- Fast-paced Momentum Stock Sonoma Pharmaceuticals (SNOA) Is Still Trading at a BargainZacks · Mar 27, 2025
- Why Fast-paced Mover Sonoma Pharmaceuticals (SNOA) Is a Great Choice for Value InvestorsZacks · Mar 11, 2025
The company
Sonoma Pharmaceuticals is a global healthcare leader for developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye care, dermatological conditions, podiatry, animal health care and non-toxic disinfectants. The company's products are clinically proven to reduce itch, pain, scarring, and irritation safely and without damaging healthy tissue. In-vitro and clinical studies of HOCl show it to safely manage skin abrasions, lacerations, minor irritations, cuts, and intact skin. The company's products are sold either directly or via partners in over 55 countries worldwide and the company actively seeks new distribution partners. The company's principal office is in Boulder, Colorado, with manufacturing operations in Guadalajara, Mexico. European marketing and sales are headquartered in Roermond, Netherlands. More information can be found at www.sonomapharma.com.
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- Exchange
- NASDAQ-CM
- Region
- North America
- Website
- sonomapharma.com
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.